Plain-English translation of NCT07140900 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new medication called to see if it can help treat advanced prostate cancer when combined with existing hormone-blocking drugs. Researchers want to understand how safe the medication is and whether it helps patients live longer or feel better. You would receive the new treatment along with one of two standard prostate cancer medications (either or ).
Men with advanced prostate cancer that has spread throughout the body need better treatment options. This medication targets cancer cells in a new way, and researchers believe combining it with existing hormone therapies might improve outcomes for patients who are newly diagnosed with this type of cancer.
You would take along with either or (whichever your doctor chooses) as your ongoing treatment. You would visit the clinic regularly for check-ups, blood tests, and scans to monitor how the treatment is working and any side effects. The trial would follow you for up to 3 years from your first dose, or until you choose to stop, lose contact with the research team, or pass away—whichever comes first.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United States